University of California, San Francisco
Appointed in 2007
Read more
University of California, San Francisco
Appointed in 2007
Harvard University School of Public Health
Appointed in 2018
Read more
Harvard University School of Public Health
Appointed in 2018
To proliferate, cancer cells activate diverse biosynthetic pathways, and determining the critical metabolic pathways will allow new therapies to be developed. Recent studies of cancer metabolism have examined pathways to generate amino acids, nucleotides, and lipids. Studies of lipid metabolism have been largely confined to understanding how cells generate the precursors for de novo lipid synthesis; however, how cells determine the fates of these lipids and how these pathways contribute to proliferation remain undefined. I propose to study the regulation of lipid metabolism downstream of proliferative signaling via the PI3K-mTORC1 network. mTORC1 is a master regulator of cellular metabolism that promotes key anabolic processes, including fatty acid synthesis. My preliminary data suggest that this kinase also regulates the fate of specific lipid pools, favoring synthesis of phospholipids over triglycerides. My proposed studies will define the mechanism and consequences of this regulation. Activating lipid synthesis allows cells to couple membrane expansion to other biosynthetic processes, and I will determine whether the programmed changes in lipid metabolism represent a vulnerability of cells with oncogenic activation of mTORC1. Collectively this study will advance current knowledge of how oncogenic signaling influences cancer metabolism and will define how lipid metabolism contributes to cancer cell proliferation.
Massachusetts Institute of Technology
Appointed in 2000
Read more
Massachusetts Institute of Technology
Appointed in 2000
Harvard University
Appointed in 1991
Massachusetts Institute of Technology
Appointed in 1971
Read more
Massachusetts Institute of Technology
Appointed in 1971
Johns Hopkins University
Appointed in 1980
Harvard University Medical School
Appointed in 2019
Read more
Harvard University Medical School
Appointed in 2019
I have always been fascinated by the individual machines of the cell called organelles. In undergrad, I tagged yeast cells with a fluorescent mitochondria reporter. When I looked under the microscope, I was fully hooked. The microscopic world inside the cell was much more elaborate that I could have ever imagined. Subsequently, I decided to continue on to graduate school and study the endoplasmic reticulum (ER) in mammalian cultured cells. The ER is often pictured as this static platform for protein synthesis, but using live cell fluorescence microscopy, you can see how the ER dynamically rearranges its structure: tubules grow out or retract, sheets shrink or expand. This drives a constant remodeling process. For my PhD thesis, I focused on why and how the ER remodels its structure to contact other organelles.
In my current work, I now get to study organelles in neurons. A specialized cell like a neuron maintains a certain shape and structure to properly function. Cells can clear away damaged organelles through the “self eating” process of autophagy. Interestingly, prior evidence indicates that autophagy machinery is needed for human embryonic stem cell differentiation to different cell states. However, to date, there is no established systematic map of organelle-phagy for stem cell conversion to a neuron. Additionally, in human patients with neurodegenerative diseases, including Parkinson’s disease, many identified gene variants are in autophagy-regulating genes. In my work, I genetically edit and tag stem cells using CRISPR and then convert these cells to neurons. With these engineered induced neurons, I study organelle structure, dynamics, and turnover in order to reveal the underlying mechanisms sustaining the architecture required for healthy and efficient neuronal function.
National Cancer Institute
Appointed in 1994
Read more
National Cancer Institute
Appointed in 1994
Fred Hutchinson Cancer Center
Appointed in 2023
Read more
Fred Hutchinson Cancer Center
Appointed in 2023
Aneuploidy is a hallmark of cancer development and occurs due to defects in chromosome segregation. The kinetochore, a complex consisting of over 100 different types of proteins, is required for the proper segregation of chromosomes. However, we lack an in depth understanding of the step-by-step assembly process resulting in a functional kinetochore due to the extreme molecular and temporal complexity of this complex. Dr. Changkun Hu will reconstitute kinetochore assembly in vitro and use TIRF microscopy to measure individual kinetochore protein recruitment times in Dr. Sue Biggins’ lab at the Fred Hutch. This approach will allow Dr. Hu to determine rate-limiting steps and key regulating mechanisms in kinetochore assembly and will serve as a blueprint for future studies examining the assembly of other large complexes. Furthermore, this work may reveal novel trouble points in chromosome segregation that lead to aneuploidy in cancer.
As a PhD student in Dr. Nicholas Wallace’s lab at Kansas State University, Dr. Hu’s research focused on the repair of DNA double-strand breaks (DSBs). Dr. Hu demonstrated that beta human papillomavirus type 8 protein E6 (8E6), long known to impair traditional DNA-repair pathways, also promotes DNA repair via a mutagenic DSB repair pathway termed alternative end joining. In this way, 8E6 promotes cancer development by increasing genomic instability. Dr. Hu will now pivot to study genome stability at the chromosome level in Dr. Biggins’ lab.
Whitehead Institute for Biomedical Research
Appointed in 1998
Read more
Whitehead Institute for Biomedical Research
Appointed in 1998
Yale University School of Medicine
Appointed in 2003
Washington University in St. Louis
Appointed in 1997
Read more
Washington University in St. Louis
Appointed in 1997
Stanford University
Appointed in 2014
Rockefeller University
Appointed in 1972
Read more
Rockefeller University
Appointed in 1972
University of California, San Francisco
Appointed in 2015
Read more
University of California, San Francisco
Appointed in 2015
I am applying quantitative engineering approaches to study collective cell phenomena in cancer. Different cells in tumors develop different sets of mutations over time, creating a range of cell clones. One view of the role of cancer mutations is that they enable a small number of progressively malignant clones to take over the tumor one after another. However, mutations can have more complicated effects on tumor progression because their outward effects on the growth of a clone can depend on who their neighbors are. Therefore, I want to understand how cancer mutations affect the overall fitness of tumors by directly measuring it, not just in the cells that contain mutations, but also in neighboring cells. My research aims to shed light on how benign tumors make the transition to proliferative, invasive tumors; perhaps uncovering an Achilles heel to the manipulation of normal cells by mutant ones, leading to new types of cancer therapies.
New York University
Appointed in 2006
Purdue University
Appointed in 1972
Imperial Cancer Research Fund Laboratories, England
Appointed in 1974
Read more
Imperial Cancer Research Fund Laboratories, England
Appointed in 1974
Harvard University Medical School
Appointed in 2013
Read more
Harvard University Medical School
Appointed in 2013
Harvard University
Appointed in 1970
University of Texas Southwestern Medical Center
Appointed in 1992
Read more
University of Texas Southwestern Medical Center
Appointed in 1992
Massachusetts Institute of Technology
Appointed in 1998
Read more
Massachusetts Institute of Technology
Appointed in 1998
Salk Institute for Biological Studies
Appointed in 1970
Read more
Salk Institute for Biological Studies
Appointed in 1970
Stanford University
Appointed in 1966
Harvard University
Appointed in 1978
Duke University
Appointed in 1987
University of California, San Francisco
Appointed in 1994
Read more
University of California, San Francisco
Appointed in 1994
Harvard University
Appointed in 2021
Read more
Harvard University
Appointed in 2021
Cancer metastasis and immune cell migration require motile movement, meaning the cell membrane must slip relative to the cytoskeleton. Thus, membrane-cytoskeleton attachments in motile cells likely rearrange, allowing tension to propagate across the membrane. In the current literature, there are ~106-fold discrepancies in reported timescales of membrane tension propagation. I hypothesize these discrepancies reflect variability between cell types, arising from differences in membrane microstructure. I specifically hypothesize that in motile cells, transmembrane proteins are arranged to allow membrane flow, enabling rapid tension equilibration, while non-motile cell membranes are structured to impede tension propagation.
I will directly measure tension propagation timescales in motile and non-motile cells and simultaneously characterize the arrangement of cytoskeleton-anchored transmembrane proteins. I will use optical tweezers to stretch membrane tethers, perturbing and measuring tension. I will visualize immobile transmembrane proteins with targeted photochemical labeling and high-resolution fluorescence imaging, revealing how transmembrane protein arrangement regulates membrane fluidity, and how cancer cells might exploit this to metastasize
University of California, Berkeley
Appointed in 1958
Read more
University of California, Berkeley
Appointed in 1958
Harvard University Medical School
Appointed in 2003
Read more
Harvard University Medical School
Appointed in 2003
Institut Pasteur, France
Appointed in 1995
University of Cambridge, England /
Yale University
Appointed in 1986
Read more
University of Cambridge, England / Yale University
Appointed in 1986
Stanford University
Appointed in 1983
Harvard University Medical School
Appointed in 2007
Read more
Harvard University Medical School
Appointed in 2007
Harvard University
Appointed in 1979
Harvard University
Appointed in 1972
University of Massachusetts Medical School
Appointed in 1975
Read more
University of Massachusetts Medical School
Appointed in 1975
Rockefeller University
Appointed in 2003
Boston Children's Hospital
Appointed in 2020
Advancements in vaccine design and immunotherapy have helped us gain insights into how to promote immunity against infections or cancers. However, excessive inflammation associated with immunotherapies, autoimmune diseases, non-healing wounds and even COVID19 is currently at the center of healthcare challenges. Following an inflammatory insult, such as an injury or pathogen invasion, immune cells in the tissues are crucial to resolve inflammation and regain healthy tissue function. Damaging inflammatory signals also activate nearby high threshold sensory neurons– the nociceptors – which are responsible for initiating pain and guarding/withdrawal responses which is believed to prevent further tissue damage. While it is conceivable that nociceptors can cooperate with immune to promote healing, the role of these neurons in shaping the healthy immune landscape of barrier tissues is currently unexplored. In the Woolf lab, I aim to determine the role of nociceptor sensory neurons in restoring the healthy immune profile of barrier tissues following an adverse and painful inflammatory event and develop novel strategies to manipulate neuroimmune interactions using genetic and pharmacological methods. Traditionally, inflammatory conditions are treated with broad immunosuppressants that put the patients at risk for further infections. The ability to fine tune immune function by controlling specific neuronal signals will offer a safer and effective therapeutic strategy for various inflammatory diseases as well as malignancies.
University of California, Los Angeles
Appointed in 2016
Read more
University of California, Los Angeles
Appointed in 2016
The mitochondrion is a subcellular organelle that is the center of energy production, calcium signaling, apoptosis and redox balance for the cell. Therefore, many diseases and normal aging run their molecular course through the mitochondrion. Uniquely, the mitochondrion contains its own DNA and makes RNA and proteins independently from the rest of the cell. This orthogonal system had presented a problem for studying the mitochondrion as the usual genetic tools of the nuclear genome are not available. However, I am using the tools of synthetic biology to allow specific interrogation of mitochondrial protein synthesis in healthy and diseased human cells._x000D_
_x000D_
In addition to studying mitochondrial protein synthesis, I am developing the yeast mitochondrion as a platform for synthetic biology in order to greatly expand the genetic code and to speed up laboratory evolution. These tools will allow creation of novel therapeutic biopolymers and proteins.
University of California, San Francisco
Appointed in 1983
Read more
University of California, San Francisco
Appointed in 1983
Stanford University
Appointed in 1984
University of Wisconsin, Madison
Appointed in 1990
Read more
University of Wisconsin, Madison
Appointed in 1990
University of California, San Francisco
Appointed in 2008
Read more
University of California, San Francisco
Appointed in 2008
My research involves the reconstruction of the T-cell antigen receptor signaling pathway in an orthogonal cell line to piece apart the molecular details of immune cell triggering, and how the system’s specificity and sensitivity can be genetically encoded.
I am originally from England and did both my undergraduate biochemistry degree and doctoral work at the University of Oxford. Throughout this period, my thoughts became increasingly focused on how signals are transmitted across the impermeable cell membrane, especially where the receptor responsible has no enzymatic activity of its own. For me, this area of research combines cell biology, biochemistry and systems analysis into one very exciting topic which, when applied to cells of the immune system, can have clear implications for new points of therapeutic intervention. Relocating to San Francisco for my postdoc has also provided me with great insights into the similarities and differences between approaches to scientific research on opposite sides of the Atlantic. I hope to combine the best of both worlds when starting my independent career in the near future.
Yale University
Appointed in 1979
Stanford University
Appointed in 2010
Working in the lab of K. Christopher Garcia, I am studying the assembly and three-dimensional structures of Wnt-receptor complexes in order to understand Wnt signaling mechanisms, and facilitate development of new strategies to clinically target Wnt-associated diseases.
I have always enjoyed studying biological problems, particularly using structural and biochemical methods to understand underlying molecular mechanisms.  I am most fascinated by fundamental and hard problems that require creativity, tenacity and dedication to solve.  After having studied fundamental aspects of protein translocation, I now wish to examine receptor-ligand interactions with high relevance to human disease. Wnt signaling is important in many developmental and regenerative processes, and in a variety of human diseases, including many types of cancers. However, due to major technical difficulties, there is a complete lack of extracellular structural information about Wnt signaling activation and inhibition. We are using traditional and novel methodologies to obtain structural information that can ultimately facilitate the development of new strategies to therapeutically target Wnt signaling. Most of my spare time is spent running over the hills behind Stanford to train for a marathon, relax from hard work, and think about new ways to approach scientific problems.
Stanford University
Appointed in 1985
University of California, Berkeley
Appointed in 1968
Read more
University of California, Berkeley
Appointed in 1968
Montefiore Hospital
Appointed in 1961
Columbia University
Appointed in 1971
Cold Spring Harbor Laboratory
Appointed in 1971
Read more
Cold Spring Harbor Laboratory
Appointed in 1971